Molecular pathogen detection

Ended Awarded Last action

Contract number
36C24822N0132
Awardee
Awarding agency
Obligated
$168,113

Award facts

Contract value 98% obligated
  • $168,113.40 Current, with exercised options
  • $171,925.20 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Riviera Beach, FL 33410, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$3,812
Original award $171,925

About this award

This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's own General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award, valued at $171,925.20, is for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to procure Biofire's diagnostic testing capabilities on an as-needed basis. Biofire has previously received multiple federal contract and grant awards from VHA, the Defense Health Agency, Department of Health and Human Services Indian Health Service, and the Department of State for a variety of infectious disease testing products and services. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 36C24822N0132?

36C24822N0132 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 1, 2021.

How much is contract 36C24822N0132 worth?

The government has obligated $168,113 on 36C24822N0132. Its potential value, with all options, is $171,925.

Is contract 36C24822N0132 an order under another contract?

Yes. 36C24822N0132 is a BPA call under V797D30085-36C24820A0028, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C24822N0132 competed?

The extent of competition for 36C24822N0132 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award